Published in Antimicrob Agents Chemother on December 01, 1987
Fluoroquinolone antimicrobial agents. Clin Microbiol Rev (1989) 6.45
In vitro and in vivo uptake of azithromycin (CP-62,993) by phagocytic cells: possible mechanism of delivery and release at sites of infection. Antimicrob Agents Chemother (1989) 3.90
Fluorometric measurement of ofloxacin uptake by human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1989) 1.69
Lack of effective bactericidal activity of new quinolones against Brucella spp. Antimicrob Agents Chemother (1991) 1.59
Antimycobacterial spectrum of sparfloxacin and its activities alone and in association with other drugs against Mycobacterium avium complex growing extracellularly and intracellularly in murine and human macrophages. Antimicrob Agents Chemother (1991) 1.54
Uptake and intracellular activity of an optically active ofloxacin isomer in human neutrophils and tissue culture cells. Antimicrob Agents Chemother (1990) 1.51
Present and future therapeutic strategies for melioidosis and glanders. Expert Rev Anti Infect Ther (2010) 1.45
Interactions between HMR 3647, a new ketolide, and human polymorphonuclear neutrophils. Antimicrob Agents Chemother (1998) 1.42
In vitro and in vivo intraleukocytic accumulation of azithromycin (CP-62, 993) and its influence on ex vivo leukocyte chemiluminescence. Antimicrob Agents Chemother (1992) 1.29
Interference of antibacterial agents with phagocyte functions: immunomodulation or "immuno-fairy tales"? Clin Microbiol Rev (2000) 1.26
Comparative in vitro activities of ofloxacin, difloxacin, ciprofloxacin, and other selected antimicrobial agents against Brucella melitensis. Antimicrob Agents Chemother (1989) 1.22
In vitro activity of the new difluorinated quinolone sparfloxacin (AT-4140) against Mycobacterium tuberculosis compared with activities of ofloxacin and ciprofloxacin. Antimicrob Agents Chemother (1991) 1.19
In vitro and in vivo ciprofloxacin pharmacokinetics in human neutrophils. Antimicrob Agents Chemother (1991) 1.16
Antibiotic penetration of and bactericidal activity within endothelial cells. Antimicrob Agents Chemother (1994) 0.99
In vitro demonstration of transport and delivery of antibiotics by polymorphonuclear leukocytes. Antimicrob Agents Chemother (1992) 0.96
Accumulation of a newly developed fluoroquinolone, OPC-17116, by human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1993) 0.95
Activity of topoisomerase inhibitors against Pneumocystis carinii in vitro and in an inoculated mouse model. Antimicrob Agents Chemother (1993) 0.91
Intracellular activity of tosufloxacin (T-3262) against Salmonella enteritidis and ability to penetrate into tissue culture cells of human origin. Antimicrob Agents Chemother (1990) 0.89
Efficacy of NY-198 against experimental Legionnaires disease. Antimicrob Agents Chemother (1988) 0.88
Mechanism of therapeutic effectiveness of cefixime against typhoid fever. Antimicrob Agents Chemother (2001) 0.87
Clindamycin suppresses endotoxin released by ceftazidime-treated Escherichia coli O55:B5 and subsequent production of tumor necrosis factor alpha and interleukin-1 beta. Antimicrob Agents Chemother (1999) 0.87
Activity of intracellular antibiotics. Infection (1991) 0.86
Uptake and intracellular activity of AM-1155 in phagocytic cells. Antimicrob Agents Chemother (1996) 0.83
Uptake and intracellular activity of NM394, a new quinolone, in human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1996) 0.82
Effects of enrofloxacin on porcine phagocytic function. Antimicrob Agents Chemother (1999) 0.79
Differential intracellular efficacies of ciprofloxacin and cefixime against Neisseria gonorrhoeae in human fallopian tube organ culture. Antimicrob Agents Chemother (1997) 0.78
Azithromycin inhibition of intracellular Legionella micdadei. Antimicrob Agents Chemother (1993) 0.78
Entry of sanfetrinem into human polymorphonuclear granulocytes and its cell-associated activity against intracellular, penicillin-resistant Streptococcus pneumoniae. Antimicrob Agents Chemother (1998) 0.76
Penetration of brodimoprim into human neutrophils and intracellular activity. Antimicrob Agents Chemother (1996) 0.76
Quinine uptake by human polymorphonuclear neutrophils. Antimicrob Agents Chemother (1991) 0.76
Intraoperative concentrations of ofloxacin in serum, bile fluid, and gallbladder wall tissue. Antimicrob Agents Chemother (1990) 0.75
Antibiotic uptake by alveolar macrophages. J Lab Clin Med (1980) 4.69
Killing of intraleukocytic Staphylococcus aureus by rifampin: in-vitro and in-vivo studies. J Infect Dis (1972) 4.40
Interaction of intraleukocytic bacteria and antibiotics. J Clin Invest (1973) 3.96
Antibiotic entry into human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1982) 3.62
Susceptibility of Legionella pneumophila to ofloxacin in vitro and in experimental Legionella pneumonia in guinea pigs. Antimicrob Agents Chemother (1985) 2.87
Clindamycin uptake by human neutrophils. J Infect Dis (1981) 2.49
Gentamicin antibacterial activity in the presence of human polymorphonuclear leukocytes. Antimicrob Agents Chemother (1979) 2.42
Membrane transport of clindamycin in alveolar macrophages. Antimicrob Agents Chemother (1982) 2.15
Uptake of h-dihydrostreptomycin by macrophages in culture. Infect Immun (1970) 1.97
Induction of increased calcium uptake in mouse T lymphocytes by concanavalin A and its modulation by cyclic nucleotides. Nature (1975) 1.82
Interactions of antibiotics and phagocytes. J Antimicrob Chemother (1983) 1.69
Effects of phagocytosis on antibiotic and nucleoside uptake by human polymorphonuclear leukocytes. J Infect Dis (1984) 1.66
Intracellular penetration and antimicrobial activity of antibiotics. J Antimicrob Chemother (1983) 1.58
The antimicrobial activity of ciprofloxacin against Legionella species and the treatment of experimental Legionella pneumonia in guinea pigs. J Antimicrob Chemother (1986) 1.51
High-performance liquid-chromatographic assay of aminoglycoside antibiotics in serum. Clin Chem (1978) 1.34
Fluorimetric determination of erythromycin and erythromycin ethylsuccinate in serum by a high-performance liquid chromatographic post-column, on-stream derivatization and extraction method. J Chromatogr (1978) 0.95
High-performance liquid chromatographic methods for determination of gentamicin in biological fluids. J Chromatogr (1981) 0.87
[The application of molecular biology to the diagnosis of mycobacteriosis]. Kekkaku (1995) 0.75
[DNA probe and polymerase chain reaction for detection and identification of mycobacteria]. Kekkaku (1992) 0.75
[A case of pulmonary tuberculosis developed immediately after a chest wall injury]. Kekkaku (1994) 0.75
[A drug delivery system and biological response modifiers for the treatment of mycobacterial infection]. Kekkaku (1994) 0.75
A case of pulmonary tuberculosis arising at the site of injury. Injury (1995) 0.75